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Introduction {#sec1}
============

Maternal smoking during pregnancy is an established risk factor for birth defects such as miscarriage, growth restriction, and premature birth ([@bib29]). It is closely associated with adverse neurobehavioral, cardiovascular, respiratory, endocrine, and metabolic outcomes in the offspring, which can persist into adulthood ([@bib25]). Nicotine, the main chemical constituent of tobacco smoking, is primarily responsible for the elevated risk ([@bib25]). Unfortunately, the introduction and spread of new tobacco products containing nicotine, such as e-cigarettes, is reversing recent progress toward reduction of tobacco use ([@bib5]).

A large body of research has elucidated the negative effects of nicotine in animals, mainly in rodent models. Animal studies have demonstrated that nicotine exposure during pregnancy has detrimental effects on fetal development, such as cellular damage, increased inflammation ([@bib47]), oxidative stress ([@bib35]), endoplasmic reticulum stress ([@bib74]), and impaired cell replication ([@bib55], [@bib64]). The suitability of clinical translation of these studies, however, remains questionable due to interspecies physiological differences and uncertainty over the degree and route of nicotine exposure ([@bib71], [@bib73]). To address these issues, some studies have attempted to study the effects of nicotine using human cells. For example, using microarray analysis, [@bib36] demonstrated that tobacco smoke and nicotine have lineage- and stage-specific effects on differentiated human embryonic stem cell (hESCs).

Although the *in vitro* differentiation of embryonic body (EB) model can be used to mimic early developments from pre-implantation epiblasts to lineage-committed progenitors, conventional bulk RNA sequencing (RNA-seq) analysis has limitations for studying the individual cellular heterogeneity within the EBs. With the recent advent of microdroplet-based single-cell RNA-seq (scRNA-seq) technologies, it is now feasible to analyze transcriptomes at the single-cell level within heterogeneous cell populations ([@bib8], [@bib50]). Here, we used scRNA-seq of EBs to characterize the effects of nicotine on hESC differentiation. We found that nicotine exposure reduced cell viability and increased reactive oxygen species (ROS), resulting in aberrant formation and differentiation of EBs. Nicotine exposure also altered cell cycling in endothelial, stromal, and muscle progenitor cells differentiated from hESCs. Furthermore, nicotine caused lineage-specific effects and dysregulated cell-to-cell communication. We found abnormal Ca^2+^ signaling pathways in muscle cells upon nicotine exposure that was verified using hESC-derived cardiomyocytes. Taken together, the effects of nicotine exposure on hESC differentiation at the single-cell transcriptomic level offer new insights into mechanisms of nicotine toxicity on early embryonic development, and can provide new tools for optimizing drug toxicity screening.

Results {#sec2}
=======

scRNA-Seq Analysis Reveals Six Major Types of Progenitor Cells {#sec2.1}
--------------------------------------------------------------

To investigate the effects of nicotine on hESC differentiation, we performed microdroplet-based scRNA-seq to identify unique cell lineages on day 21 control and nicotine-exposed EBs ([Figure 1](#fig1){ref-type="fig"}A). We used 10 μM nicotine exposure for 21 days, which is similar to nicotine concentrations found in fetal serum ([@bib41]) and has been used in prior hESC studies ([@bib24], [@bib78]). After dissociation, transcriptomic data of 5,646 single cells from nicotine-exposed EBs and 6,847 single cells from control EBs were acquired. Sequenced data showed high read depth, and were mapped to approximately 3,000 median genes per cell ([Figure S1](#mmc1){ref-type="supplementary-material"}A, left). The percentage of mitochondrial genes present in most cells was less than 10% ([Figure S1](#mmc1){ref-type="supplementary-material"}A, right). We used the Seurat package ([@bib57]) to perform principal-component analysis and t-distributed stochastic neighbor embedding (t-SNE) analysis. Control EBs were divided into 13 clusters, and nicotine-exposed EBs were divided into 12 clusters that exhibited distinct gene expression patterns ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Control and nicotine-exposed EBs contained similar cell-type markers, without any observed differences in cell types between the two samples ([Figure S1](#mmc1){ref-type="supplementary-material"}B).Figure 1scRNA-Seq Analysis Reveals Cell Lineages in Control and Nicotine-Exposed Embryoid Bodies(A) Process flow diagram of scRNA-seq analysis on hESC differentiation. Single cells were collected from two independent EB differentiation experiments from day 21 EBs (nicotine-exposed versus control) and were prepared by single-cell barcoded droplets and chemicals from 10× Genomics. Bioinformatics data were processed using Seurat. Cell-type marker, differentially expressed gene, cell communication, and pathway analyses were performed to investigate the effects of nicotine exposure on hESC differentiation.(B) Separated (left) and combined (middle and right) t-SNE plots of single cells from control and nicotine-exposed EBs. We defined six main types of progenitor cells in day 21 EBs, including muscle progenitor cells (clusters 3 and 13), liver progenitor cells (cluster 5), neural progenitor cells (clusters 3, 4, 8, and 11), stromal progenitor cells (cluster 6), epithelial progenitor cells (clusters 2 and 12), and endothelial progenitor cells (cluster 11). In addition, undifferentiated stem-like cells (USCs) (cluster 1) and undetermined cells (UDCs) (cluster 9) were also identified.(C) Heatmap showing the expression pattern of top 10 differential genes in each cell type. Representative differential genes for each cell type are listed on the right side. The complete lists of differential genes for each cell type are listed in [Table S3](#mmc3){ref-type="supplementary-material"}.(D) Violin plots show the expression level distributions of marker genes across cell types.

Next, we performed integrative analysis to compare the cell proportions and gene expression differences in each cell type between nicotine and control EBs. Nicotine exposure induced widespread transcriptomic changes, which were manifested as a shift in the t-SNE projections of singlets ([Figure 1](#fig1){ref-type="fig"}B, middle). Previous reports with bulk RNA-seq data also indicated that nicotine affects gene expression in multiple cell lineages ([@bib36]). A total of 13 individual clusters were defined from the combined datasets (termed C1 to C13) ([Figure 1](#fig1){ref-type="fig"}B, right). Based on differential genes enriched in each cluster, six major types of progenitor cells were identified by Seurat ([Figures 1](#fig1){ref-type="fig"}C and 1D). Clusters 3, 4, 8, and 10 were associated with high expression of *LHX2* and *NR2F1* ([@bib45], [@bib69]) and annotated as neural cells. Cluster 5 represented liver progenitor cells with a high expression of *FRZB* and *PTN* ([@bib46], [@bib61]). Cluster 6 was annotated as stromal progenitor cells with a high expression of *SFRP2* and *COL2A1* ([@bib56], [@bib66]). Cluster 11 was annotated as endothelial progenitor cells with high expression of *GDF15* and *DDIT3* ([@bib2], [@bib39]). Cluster 2 and 12 were annotated as epithelial progenitor cells (EpiPCs) with high expression of *IGFBP5* and *PODXL* ([@bib65], [@bib81]). Clusters 7 and 13 showed a high expression of *HAPLN1* and *S100A11*, and were annotated as muscle progenitor cells ([@bib11], [@bib42]). Cluster 1 was enriched for pluripotency genes such as *TERF1* and *POU5F1*, and was annotated as "undifferentiated stem-like cells". Cluster 9 was enriched for cytoskeletal genes such as *ACTB* and *TUBB*, and was annotated as "undetermined cells".

To further confirm our cluster annotation, we found genes specifically expressed in each cell type that were enriched for the expected appropriate gene ontology (GO) terms. For example, genes that were specifically expressed in muscle progenitor cell clusters were significantly enriched for the cytosolic Ca^2+^ pathway (p = 2.92 × 10^−11^) and skeletal system development (p = 3.36 × 10^−4^). Genes expression in the neural progenitor cell clusters were significantly enriched for nervous system development (p = 1.01 × 10^−6^) and sensory organ development (p = 5.60 × 10^−8^). Genes expression in the liver progenitor cell cluster were enriched for liver development (p = 2.52 × 10^−4^) and response to lipid (p = 1.74 × 10^−2^). Genes expression in the endothelial progenitor cell cluster were significantly enriched for blood vessel development (p = 1.3 × 10^−4^) and angiogenesis (p = 1.61 × 10^−3^). Genes expressions in the EpiPC clusters were enriched for lung development (p = 2.43 × 10^−5^) and kidney development (p = 5.67 × 10^−4^) ([Figure S1](#mmc1){ref-type="supplementary-material"}D).

It should be noted that neural, muscle, and epithelial progenitor cells consisted of several sub-clusters. Neural progenitor cells were further divided into four subsets: clusters 3, 4, 8, and 10. Cluster 3 showed a high expression of *LHX5/HESX1* that is related to forebrain development ([@bib43], [@bib80]). Cluster 4 was enriched for *HMGB2* and *PTTG1*, which are highly expressed in proliferating neural stem cells ([@bib32]). Cluster 8 was annotated as neural progenitor cells with an enrichment of *HNRNPH1* and *PTPRS* ([@bib70], [@bib76]), which are related to sensory neurons development. Cluster 10 was enriched for *LHX2* and *NR2F1* and expressed eye development genes ([@bib45], [@bib69]). Muscle progenitor cells were divided into two subsets: clusters 7 and 13. Cluster 7 was annotated as muscle cells for the expression of *HAPLN1* and *S100A11*, which are highly expressed in smooth muscle cells ([@bib11], [@bib42]). Cluster 13 was enriched for *ZFHX3* and *NR2F2*, which are related to cardiac muscle development ([@bib6], [@bib51]). EpiPCs were divided into two subsets: clusters 2 and 12. Cluster 2 was enriched for *IGFBP5* and *HES1*, which are related to eye development ([@bib37], [@bib65]). Cluster 12 was enriched for *B3GNT7* and *PODXL*, which are highly expressed in stem-like epithelial cells ([@bib14]) ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}D).

Overall, six major types of progenitors (neural, liver, stromal, endothelial, epithelial, and muscle) were identified from scRNA-seq data of EBs based on cell markers detected by Seurat. These data may be useful for modeling nicotine exposure on individual organs and cells within the developing fetus.

Nicotine Elicits Cell-Type-Specific Response in Differentiated EBs {#sec2.2}
------------------------------------------------------------------

Integrated analysis of control and nicotine-exposed EBs at the single-cell level enables us to quantitatively assess cell-type-specific responses to nicotine. Quantification of the cell-type compositional changes showed changes from 5% reduction in epithelial progentior cells to 4% increase in liver progenitor cells following nicotine exposure ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}A). Next, we performed comparative analysis and calculated the average expression of both the nicotine-exposed and control cells to determine differentially expressed genes (DEGs) in each cell type ([Figure 2](#fig2){ref-type="fig"}B). Interestingly, there was a marked difference in the number of DEGs among different cell types, ranging from 5 to 103 genes with a *p*-value less than 0.01 and a log fold-change more than 0.25. For example, we observed 5 DEGs in liver progenitor cells with nicotine treatment, whereas muscle progenitor cells exhibited the greatest number of 103 DEGs. Among these DEGs, *BNIP3*, and metallothionein family genes (*MT1X*, *MT1G*, *MT1E*, and *MT2A*) were uniformly downregulated and *RPS10* was upregualted in most of cell types ([Figure 2](#fig2){ref-type="fig"}B). *BNIP3* gene is an important regulator during long-term nicotine-induced cell death in several cell types ([@bib15], [@bib68]). Metallothionein family genes play a role in the protection against metal toxicity and oxidative stress, and have been shown to be suppressed in chronic smokers ([@bib7]). These genes are involved in apoptosis, ROS generation, mitochondrial function, and response to metal ion pathways ([Figure 2](#fig2){ref-type="fig"}C), indicating that EBs have poor cell survival upon nicotine exposure.Figure 2Nicotine Exposure Induces Cell-Type-Specific Response(A) Cell proportion fluctuation for each cell type with nicotine exposure. Cell proportion fluctuation for each cluster with nicotine exposure is shown in [Figure S2](#mmc1){ref-type="supplementary-material"}A. USCs, undifferentiated stem-like cells; UDCs, undetermined cells; EpiPCs, epithelial progenitor cells; ECs, endothelial progenitor cells.(B) Plots of the average expression of genes from control and nicotine-exposed EBs for each cell type. Significant differentially expressed genes are labeled in the plots (p *\<* 0.05). The complete list of differentially expressed genes upon nicotine exposure for each cluster is shown in [Table S5](#mmc5){ref-type="supplementary-material"}.(C) Pathway enrichment analysis of statistically significant gene ontologies following nicotine exposure. The size of the circle represents the significance of gene ontologies, and the darkness of color represents the number of genes involved in the gene ontologies. The complete lists of differentially expressed gene-related pathways upon nicotine exposure for each cluster are listed in [Table S6](#mmc6){ref-type="supplementary-material"}.(D) Heatmap for differentially expressed genes in scRNA-seq data, public hepatic cell line (HepaRG), human gingival epithelium cell line (HGEC), human smooth muscle cells (HSMCs), and human iPSC-derived endothelial cell (hiPSC-ECs) in terms of fold-change (nicotine-exposed relative to control EBs). Each row represents a single differentially expressed gene identified in (B). The names of cell types are labeled on the left side. Differentially expressed genes in scRNA-seq data corresponding to the public datasets are labeled with a rectangle.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Nicotine also showed cell-type-specific responses. *APOE*, *TUBA1A*, and *NDUFC2* were significantly upregulated, and *H1F0* and *SRRM2* were downregulated, in neural progenitor cells ([Figures 2](#fig2){ref-type="fig"}B and 2C). Abnormal expression of these genes can lead to β-amyloid formation and increased synaptic transmission ([@bib48]), brain malformations ([@bib3]), and intellectual disability ([@bib67]). In muscle progenitor cells, the most upregulated gene following nicotine exposure was *HSP90AA1*, a myosin chaperone protein gene involved in muscle development and disease ([@bib4], [@bib16]). Increased expression of *HMGB1*, known to regulate cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum Ca^2+^ leakage through Toll-like receptor 4 (TLR4)-ROS signaling in cardiac muscle cells, was also observed ([Figures 2](#fig2){ref-type="fig"}B, 2C, and [S2](#mmc1){ref-type="supplementary-material"}C).

In stromal progenitor cells, *LDHA* and *DAPL1*, known to regulate nutrient levels and amino acid acetylation, were downregulated upon nicotine exposure ([Figures 2](#fig2){ref-type="fig"}B and 2C). *BINP3*, related to lipid metabolism, was downregulated in liver cells ([@bib20]). In epithelial progenitor cells, macrophage migration inhibitory factor (*MIF*), which is associated with chronic obstructive pulmonary disease in human, was downregulated ([@bib58]). *WDR77*, required for proliferation of lung and prostate epithelial cells during development and tumorigenesis ([@bib62]), was upregulated in epithelial progenitor cells in the presence of nicotine ([Figures 2](#fig2){ref-type="fig"}B and 2C). In endothelial progenitor cells, *LDHA*, *DDIT3*, and *IFITM1* were downregulated, and *HNRNP2B1* was upregulated upon nicotine exposure ([Figures 2](#fig2){ref-type="fig"}B and 2C). Downregulation of *LDHA* is related to the suppression of glycolysis and endothelial cell dysfunction ([@bib75]). Downregulated *DDIT3* exhibits reduced ER stress response upon long-term cigarette smoke exposure ([@bib18]). *IFITM1* downregulation is related to endothelial lumen formation during angiogenesis ([@bib52]) ([Figures 2](#fig2){ref-type="fig"}B and 2C). Likewise, we confirmed cell-type-specific responses to long-term nicotine exposure on EBs using GO pathway enrichment analysis ([Figure 2](#fig2){ref-type="fig"}C).

To determine how our analysis correlates with previously reported bulk RNA-seq data from specific cell lines, we examined the expression fold-changes of DEGs in published gene expression data after nicotine exposure, including hepatic cells (HepaRG), human gingival epithelium cells (HGECs), human smooth muscle cells (HSMCs), and human iPSC-derived endothelial cells (hiPSC-ECs) ([@bib1], [@bib22], [@bib77]). Interestingly, the trend in gene expression changes in cluster12 epithelial progenitor cell was similar to that of HGECs, whereas an opposite trend of gene expression changes was observed between cluster-2 epithelial progenitor cells and HGECs. This may be due to HGECs being more similar to stem-like "cluster-12 epithelial cell" in biological identity and more different from "cluster-2 epithelial cell". In HSMCs, the overall change of DEGs was subtle, but the trends in fold-change expression were consistent with EB-derived muscle cells. The genes downregulated in EB-derived endothelial cells also reduced their expression in hiPSC-ECs upon nicotine exposure ([Figure 2](#fig2){ref-type="fig"}D). Taken together, DEG analysis showed cell-type-specific transcriptomic changes upon nicotine exposure, which are consistent with previously reported bulk RNA-seq or microarray analysis in different cell types ([@bib1], [@bib22], [@bib77]). Our data thus provide a novel method for evaluating nicotine toxicity in heterogeneous populations of human EBs at a single-cell level.

Nicotine Dysregulates Viability, ROS Generation, and Cell Cycle in EBs {#sec2.3}
----------------------------------------------------------------------

Infants exposed to nicotine prenatally often exhibit lower birth weights than their peers ([@bib17], [@bib63]). Animal studies have shown that nicotine exposure during pregnancy induces cellular damage, oxidative stress, and impaired cell replication ([@bib55], [@bib64]). However, the molecular mechanisms remain poorly understood. Our DEG analysis showed that long-term nicotine exposure induced apoptosis and ROS generation mediated by the downregulation of *BNIP3* and metallothionein family genes ([Figures 2](#fig2){ref-type="fig"}B and 2C). Therefore, we performed several assays to confirm decreased survival of nicotine-exposed EB. Nicotine-exposed EBs were smaller than control EBs ([Figures 3](#fig3){ref-type="fig"}A and 3B), and cell viability was significantly reduced based on quantification of ATP, an indicator of metabolically active cells ([Figure 3](#fig3){ref-type="fig"}C). We also found higher levels of ROS in nicotine-exposed EBs compared with control EBs ([Figure 3](#fig3){ref-type="fig"}D).Figure 3Nicotine Reduces Cell Viability, Increases ROS Levels, and Changes Cell Cycle in EBs(A) Representative bright-field images of day 21 control and nicotine-exposed EBs. Scale bar, 100 μm.(B) Size measurement of control (n = 45) and nicotine-exposed (n = 43) EBs in terms of diameter. EBs were collected from three independent EB differentiation experiments and pooled together for size measurement. ^∗∗∗^p \< 0.001.(C) Cell viability assay of EBs based on quantitation of the ATP present in control and nicotine-exposed EBs. Cell viability were measured from three independent experiments. ^∗^p \< 0.05.(D) Reactive oxygen species (ROS) generation in control and nicotine-exposed EBs. ROS was measured from three independent experiments. ^∗^p \< 0.05.(E) Proportion of cluster 13 muscle cells in G2M, S, or G1 phase.(F) Distribution of *TUBB4B* expression in three cell-cycle phases in control (top) and the nicotine-exposed EBs (bottom). Dashed lines represent the center of G2M phase in control and nicotine-exposed EBs.

Clinical and animal studies have shown that nicotine exposure changes the dynamics of cell replication and causes growth restriction ([@bib55]). We thus analyzed cell cycling in the scRNA-seq data to evaluate the growth of EB after nicotine treatment by calculating cell-cycle phase scores based on canonical markers ([@bib49]). Relative to control EBs, nicotine-exposed EBs exhibited a 12% decrease in G1 phase, a 6% increase in G2M phase, and a 5.5% increase of S phase in endothelial progenitor cells. In stromal progenitor cells, we found an 11% decrease in G1 phase and a 12% increase in S phase ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Surprisingly, we found that there was a 20% decrease of cells in the G1 phase, a 5% increase of cells in the G2M phase, and a 15% increase of cells in S phase in the "cluster-13 muscle progenitor cell" ([Figure 3](#fig3){ref-type="fig"}E). For example, *TUBB4B*, a G2M phase marker, was differentially expressed in muscle progenitor cells from nicotine-exposed EBs versus control EBs ([Figure 3](#fig3){ref-type="fig"}F). Consequently, nicotine exposure increased ROS production and cell death in EBs and affected the cell cycle of endothelial, stromal, and muscle progenitor cells.

Nicotine Exposure Dysregulates Cell-to-Cell Communication of Differentiated EBs {#sec2.4}
-------------------------------------------------------------------------------

Smoking and nicotine consumption increase the pathological risk in endocrine, reproductive, respiratory, cardiovascular, and neurologic systems that all rely on intricate and dynamic interactions among multiple functional cell types for homeostasis and function ([@bib30], [@bib54]). The effect of nicotine on cell-to-cell communication, however, is not well understood. Recent studies using *in vitro* co-cultured systems indicate that cell-to-cell communication could be affected by nicotine exposure ([@bib26], [@bib34], [@bib38]). Our study used a dataset of human ligand-receptor pairs ([@bib53]) to define intercellular communication networks. To examine the effects of nicotine on cell-to-cell communication, we also analyzed ligand-receptor expression differences in nicotine-exposed EBs and control EBs. Overall, we observed increased intercellular communication for each EB cell type upon nicotine exposure ([Figures 4](#fig4){ref-type="fig"}A and 4B). For example, the number of ligand-receptor pairs in autocrine circuits from muscle progenitor cell was increased from 51 to 85, and the number of ligand-receptor pairs in muscle-neuron crosstalk was increased from 47 to 71 ([Figure 4](#fig4){ref-type="fig"}B).Figure 4Nicotine Increased Cell-to-Cell Communication and Induced HMGB1-TLR4 Pathway among Cell Types in EBs(A) Intercellular communication analysis among cell types in the control and nicotine-exposed EBs. Line color indicates ligands broadcast by the cell population of the same color (labeled). Lines connect to cell populations where cognate receptors are expressed. Line thickness is proportional to the number of ligands where cognate receptors are present in the recipient cell population. Loops indicate autocrine circuits. Map quantifies potential communication but does not account for anatomic position or boundaries of cell populations. Crosstalk among cell types in control and nicotine-exposed EBs are listed in [Table S7](#mmc7){ref-type="supplementary-material"}.(B) Detailed view of ligands broadcast by each cell type and those populations expressing cognate receptors primed to receive a signal. Numbers indicate the quantity of ligand-receptor pairs for each inter-population link. Colors of the cell population corresponds to (A) above.(C) Venn diagrams of ligands present in control or nicotine-exposed EBs and differentially expressed genes between control and nicotine-exposed EBs.(D) Heatmap of the expression of differentially expressed ligands in control versus nicotine-exposed EBs across different cell types in terms of average fold-change of expression. Seven ligands present in both control and nicotine-exposed EBs (labeled "both") were selected as differentially expressed ligands. Three ligands were selected as expressed only in nicotine-exposed EBs and labeled as "nicotine."(E) Intercellular communication analysis among different cell types shows activated HMGB1-TLR4 pathway upon nicotine exposure. The meaning of the thickness and color of line is explained in (A). USCs, undifferentiated stem-like cells; UDCs, undetermined cells; EpiPCs, epithelial progenitor cells; ECs, endothelial progenitor cells.

Next, we analyzed the expression of ligands in each cell type to identify 61 ligands that were expressed in both nicotine-exposed EBs and control EBs, of which 7 were differentially expressed. Seventy-five ligands were mainly expressed in nicotine-exposed EBs, of which 3 were enriched in certain cell types identified by DEG analysis ([Figures 4](#fig4){ref-type="fig"}C and 4D). One extracellular ligand, high-mobility group box 1 (*HMGB1*), was uniformly upregulated in multiple cell types of nicotine-exposed EBs, but was not presented in control EBs ([Figures 4](#fig4){ref-type="fig"}C and 4D). Previous research has shown that HMGB1 regulates Ca^2+^ handling and cellular contractility by activating its receptor Toll-like receptor 4 (TLR4) in rat cardiomyocytes, which plays an important role in the pathogenesis of cardiac dysfunction in many diseases ([@bib79]). Here, we found that HMGB1-TLR4 signaling, although not specific, was also activated in muscle progenitor cells ([Figure 4](#fig4){ref-type="fig"}E), suggesting that the activated HMGB1-TLR4 pathway may play an important role in cardiac dysfunction upon nicotine exposure.

Disturbance of Intracellular Ca^2+^ Handling in hESC-Derived Cardiomyocytes by Nicotine Exposure {#sec2.5}
------------------------------------------------------------------------------------------------

Our data indicate that nicotine affects the expression of genes associated with intracellular Ca^2+^ handling via the HMBG1-TLR4 pathway in cardiac muscle cells, and animal studies have shown that nicotine exposure disrupts intracellular Ca^2+^ homeostasis in cardiac cells ([@bib28]). To investigate whether nicotine affects the Ca^2+^ handling in cardiac muscle cells, we first checked the expression of *HMGB1* and *TLR4* in hESC-derived cardiomyocytes. The expression of *HMGB1* was increased by 2-fold, and *TLR4* increased by 90-fold in hESC-derived cardiomyocytes exposed to nicotine ([Figure 5](#fig5){ref-type="fig"}A). We next conducted single-cell Ca^2+^ measurement using Fura-2 in hESC-derived cardiomyocytes ([Figure S3](#mmc1){ref-type="supplementary-material"}). As shown in [Figures 5](#fig5){ref-type="fig"}B--5E, nicotine increased the diastolic Ca^2+^ ([Figures 5](#fig5){ref-type="fig"}B and 5C) and reduced the Ca^2+^ transient amplitude ([Figure 5](#fig5){ref-type="fig"}D), accompanied by prolonged Ca^2+^ decay ([Figure 5](#fig5){ref-type="fig"}E), suggesting compromised intracellular Ca^2+^ homeostasis. We found that nicotine increased the propensity for arrhythmic Ca^2+^ release in hESC-derived cardiomyocytes, as indicated by the arrows in [Figures 5](#fig5){ref-type="fig"}F and 5G. These data strongly suggest that nicotine increases Ca^2+^-release abnormalities at the cellular level, predisposing these cells to Ca^2+^-associated arrhythmia.Figure 5Nicotine Disrupts Intracellular Ca^2+^ Handling in hESC-Derived Cardiomyocytes(A) Real-time PCR verification of the expression levels of *HMGB1* and *TLR4* in hESC-derived cardiomyocytes for nicotine-exposed and control group. Real-time PCR was conducted from three independent differentiation experiments. Nicotine and ethanol were added during cardiomyocyte differentiation process. Ethanol-exposed hESC-derived cardiomyocytes were used as a control. ^∗∗∗^p \< 0.001.(B--E) Representative single-cell Ca^2+^ traces with and without treatment of nicotine (1 μM) (B). Cells were paced at 0.5 Hz and recorded at 37°C. Nicotine affects diastolic Ca^2+^ (C), Ca^2+^ transient amplitude (D), and Ca^2+^ uptake (E).(F) Representative arrhythmic Ca^2+^ release. The arrhythmic Ca^2+^ release is indicated by the arrows.(G) Percentage of cells with normal or arrhythmic Ca^2+^ release. Numbers indicate the recorded cell number in each condition. Recording was conducted with two independent differentiation. The cell number shows the pooled data.^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Error bars indicate SEM.

Discussion {#sec3}
==========

In this study, we performed scRNA-seq analysis on a total of 12,500 single cells generated from human ESC-derived EBs following 21 days of culture with or without nicotine ([Figure 1](#fig1){ref-type="fig"}). Previous studies have demonstrated that nicotine concentrations in fetal serum are much higher than in maternal serum, ranging from 0.3 to 15.4 μM in fetal serum ([@bib41]). Based on these reports, and the concentrations studied in other investigations of nicotine effect on hESCs (0.1--10.0 μM), we decided to use 10 μM of nicotine during hESC differentiation ([@bib24], [@bib78]). We also found that a 6-day exposure to nicotine reduces viability in hESCs ([Figure S3](#mmc1){ref-type="supplementary-material"}D), suggesting that nicotine affects embryo development as early as the pre-implantation stage.

We did not observe cell-type differences between nicotine-exposed EBs and control EBs, although there were minor changes in the cell-type distribution upon nicotine exposure. However, DEG patterns from various progenitor cell populations indicated broad effects on cells derived from all three germ layers (neural, stromal, muscle, endothelial, and epithelial progenitor cells). This is consistent with clinical observations that nicotine-exposed infants have health problems throughout their lives, including impaired function of the endocrine, reproductive, respiratory, cardiovascular, and neurologic systems ([@bib72]). In addition, although the current technology does not allow us to conduct proteomic analyses at a single-cell resolution level, we searched available nicotine-associated proteomic datasets in PubMed and found that our DEGs, HSPA8, BAX, and CKB were also reported to be upregulated in mouse neurons ([@bib44]), MIF was downregulated in human endothelial cells ([@bib79]), and that SLC25A4, REEP5, and ATP5F1 were upregulated in human epithelial cells ([@bib19]) ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Moreover, among these DEGs, *BNIP3* is uniformly downregulated in most cell types ([Figure 2](#fig2){ref-type="fig"}B). We observed downregulated BNIP3 expression in nicotine-exposed EBs compared with the control EBs at the protein level ([Figure S2](#mmc1){ref-type="supplementary-material"}D). These lines of evidence suggest that our scRNA-seq data can reflect protein expression to some extent.

Our scRNA-seq analysis suggests that downregulation of *BNIP3* and metallothionein family gene expression in multiple progenitor cell types upon nicotine exposure provides the molecular mechanisms that lead to altered DEG patterns. It has been reported that reduced BNIP3 expression correlates with poor cell survival following long-term nicotine exposure ([@bib68]). Our data indicate that hESC-derived cells adapt to long-term nicotine exposure and cell damage resulting from downregulation of *BNIP3* ([Figure 2](#fig2){ref-type="fig"}B). This may be analogous to the observed low birth weight, preterm birth, and perinatal death in a developing fetus as a result of maternal smoking during pregnancy ([@bib72]).

Nicotine also displayed cell-type-specific adverse effects, consistent with previous findings in animal and clinical studies ([@bib25]). For example, we found that *APOE* was upregulated in nicotine-exposed EBs, and it has previously been shown that upregulated *APOE* leads to brain malformations and intellectual disability ([@bib67]). In muscle cells, increased expression of HMGB1 impairs cardiac excitation-contraction ([@bib79]) and increases nicotine-induced risk for Ca^2+^-associated arrhythmias ([Figure 5](#fig5){ref-type="fig"}). In addition, the DEGs identified by scRNA-seq analysis are similar to bulk transcriptome studies performed in human cell lines ([Figure 2](#fig2){ref-type="fig"}D).

Interestingly, we found that nicotine dysregulates the cell cycle of endothelial, stromal, and muscle progenitor cells from G1 phase to S/G2M phases. Previous studies have also shown that nicotine stimulates the cell cycle in aortic smooth muscle cells, epithelial cells, and lung cancer cells ([@bib23]). One study shows that nicotine enhances proliferation and induces cyclin D1 to stimulate G1 to S/G2 phase transition in human bronchial smooth muscle cells ([@bib27]), which is consistent with our findings in cluster-13 muscle progenitor cells. A possible mechanism is that nicotine activates RAS/MAPK pathway via nicotinic acetylcholine receptors (nAChRs) to trigger a network that positively regulates cell-cycle progression through G1 to S, such as cyclin D ([@bib27]). Here, although no expression difference was observed on cyclin D and RAS/MAPK in our scRNA-seq data, we found that the components of cell-cycle machinery, such as *HSP90AA1*, *TUBB4B*, and *TUBA1B*, which are related to G2M transition ([@bib13]), and *HNRNPH1* and *HNRNPA2B1*, which are related to G1 to S transition ([@bib13]), are upregulated in nicotine-exposed muscle cell cluster 3.

As such, scRNA-seq analysis provides a robust tool for investigating cell-to-cell interactions ([@bib30], [@bib54]) in development and disease pathobiology. In particular, an activated HMGB1-TLR4 pathway was pronounced in multiple cell types within EBs upon nicotine exposure. High expression of *HMGB1* in multiple organs, perhaps induced by the secondary effects of nicotine such as oxidative stress, apoptosis, and inflammatory factors ([@bib40], [@bib59], [@bib31]), and is known to mediate multiple pathological conditions ([@bib33]), has been shown in smokers. For example, upregulated HMGB1 impairs cardiac excitation-contraction coupling by enhancing sarcoplasmic reticulum Ca^2+^ leakage through TLR4-ROS signaling in cardiomyocytes ([@bib79]). This indicates that HMGB1 could be a potential drug target for nicotine-induced embryonic defects.

Nicotine has been suggested to mediate its function via an nAChR-dependent or -independent pathway. Nicotinic receptors are expressed in undifferentiated and differentiating cells ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Studies have shown that nAChRs mediate apoptosis, cell proliferation, cell differentiation, regulation of intracellular calcium, oxidative stress, and inflammation by nicotine ([@bib10]). In addition, nicotine is reported to promote tumor progression by binding to β-adrenergic receptors ([@bib9]). In addition, nicotine drives both cell proliferation and cell death via paracrine signaling by cell-cell interaction ([@bib12], [@bib59]). Thus, nicotine may induce the adverse effects of EBs through nAChR-dependent and -independent pathways, as well as cell-cell interaction.

Furthermore, scRNA-seq analysis can be used to optimize the treatment manner and period of drug use for patient-specific drug screening/testing. For example, with the increasing availability of commercial human genomic sequencing data, we can evaluate embryonic developmental-specific drug responses with (single nucleotide polymorphism) SNPs, and the response can be confirmed by gene editing with the CRISPR technology ([@bib60]). Specifically, the SNP (rs141819830) of the *GFI1* gene has been reported to be sensitive to maternal smoking in exposed neonates ([@bib21]). Thus, we may be able to use patient-specific hiPSC-derived EBs carrying this SNP to evaluate the risk of nicotine toxicity on embryonic development. We anticipate that this platform should help correlate the risk of the *GFI1* SNP gene with maternal smoking during pregnancy.

In summary, we used microdroplet-based scRNA-seq to investigate the adverse effects on heterogeneous EBs upon nicotine exposure. Our study offers an effective platform to evaluate the potential effects of nicotine on human embryonic development. Our data provide potential molecular mechanisms for prenatal nicotine toxicity on specific cell populations derived from human ESCs.

Cell Culture and Differentiation {#sec3.1}
--------------------------------

hESC line, H7 (WiCell Research Institute), was seeded on Matrigel (BD Bioscience)-coated plates in Essential 8 Medium (Thermo Fisher Scientific). We generated EBs by clone suspension. EBs were differentiated in DMEM/F12 (Gibco) supplemented with 20% FBS (Gibco), 50 U/mL penicillin/streptomycin (Gibco), 2 mM L-glutamine (Gibco), 1× non-essential amino acids, and 100 μM β-mercaptoethanol (Sigma). At 90% confluency, hESCs were digested using 1 mL Gentle Cell Dissociation Reagent (STEMCELL Technologies) for 5 min. Cell clumps were pipetted into single cells, and 9.0 × 10^5^ cells per well were seeded into AggreWell 800 (STEMCELL Technologies). The day after seeding, EBs/spheroids were harvested from AggreWell 800 plates and transferred into an ultra-low attachment six-well plate (Corning). Nicotine (10 μM; N3876, Sigma) was added into the differentiating medium, and EBs were fed each day for 21 days. The same volume of ethanol (459836, Sigma) was added into the differentiating medium as control.

scRNA-Seq Library Preparation and Analysis {#sec3.2}
------------------------------------------

Single cells were collected from two independent EB differentiation experiments from day 21 EBs (control and nicotine-exposed) and dissociated using Accutase (STEMCELL Technologies). They were prepared for the single-cell library separately. In brief, cells were washed with 1× DPBS (Gibco) three times, strainer filtered, and re-suspended in 0.04% BSA. Viable single cells were loaded on to a GemCode Instrument (10× Genomics, Pleasanton, CA) to generate single-cell barcoded droplets (GEMs) using the 10× Single Cell 3′ v.2 chemistry and 10× Chromium system as per the manufacturer\'s protocol. The quality of the resulting libraries was checked with Bioanalyzer (Agilent Bioanalyzer 2100). Then control and nicotine libraries were combined with equal molar mass and sequenced across two lanes on an Illumina HiSeq machine. Analyses was performed using Seurat R package. Detailed scRNA-seq analysis is available in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

EB Diameter Measurement {#sec3.3}
-----------------------

Bright-field images were captured by an SI8000 Cell Motion Imaging System (Sony Biotechnology) using a 4× objective. Scale was set with a 20-cm-ruler image. The diameter of each EB was measured by drawing a selection line of longest distance in each EB using the Line Selection tool in ImageJ. Analyses were processed with ImageJ and the results were plotted with Prism (GraphPad).

Quantification of ROS Production and ATP {#sec3.4}
----------------------------------------

ROS production level and ATP level in EBs were determined using CellTiter-Glo 2.0 (Promega) and ROS-Glo H~2~O~2~ (Promega) following the manufacturers\' instructions. In brief, EBs were exposed to nicotine in 96-well plates for 21 days. After treatment, H~2~O~2~ substrate was added directly to each well of 96-well plates and incubated for 4 h. The resulting supernatant was collected for ROS-Glo H~2~O~2~ assay and EBs were subsequently subjected to the CellTiter-Glo 2.0 assay to measure the ATP level. The luminescence intensity was measured using a Synergy HTX multi-mode microplate reader (BioTek).

Intracellular Calcium Imaging {#sec3.5}
-----------------------------

Single hESC-derived cardiomyocytes were plated onto Matrigel-coated coverglass (CS-24/50, Warner Instruments) at a density of ∼10,000 cells per square centimeter. Cells were allowed to recover for 3--4 days and loaded with 5 μM Fura-2 AM (Thermo Fisher Scientific) in Tyrode\'s solution (140 mM NaCl, 5.4 mM KCl, 1 mM MgCl~2~, 10 mM glucose, 1.8 mM CaCl~2~, and 10 mM HEPES; pH adjusted to 7.4 with NaOH at room temperature) for 30 min at room temperature. Cells were imaged on a customized Ti-S/L 100 Inverted Microscope-based imaging platform with a 40× oil immersion objective (CFI Super Fluor, NA 1.30 WD 0.22). Bipolar pulse was used to pace cells at 0.5 and 1 HZ. Cells were kept at 37°C while recording. Fura-2 signals were captured in high-frame-rate video recording mode (512 × 512 pixels) at a speed of 50 frames per second. Videos were analyzed with NIS Elements Advanced Research Software (Nikon), and raw ratio-pair data were further processed with a custom-made script based on Interactive Digital Language.
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Accession Numbers {#app1}
=================
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